吳冰冰 蘇雅潔 王慧君 張 萍 李 龍 周文浩,3,5

·論著·

KMT2D基因突變所致的Kabuki綜合征6例報(bào)告并文獻(xiàn)復(fù)習(xí)

吳冰冰1,3,4蘇雅潔2，4王慧君1張 萍1李 龍2，5周文浩1,3,5

目的 探討KMT2D突變引起的Kabuki綜合征(KS)的臨床、遺傳學(xué)特點(diǎn)及其在新生兒期的臨床特征。方法 采用全外顯子組測(cè)序(WES)和臨床panel的二代測(cè)序技術(shù)，結(jié)合復(fù)旦大學(xué)附屬兒科醫(yī)院分子診斷中心建立的數(shù)據(jù)分析流程，行相關(guān)基因測(cè)序和數(shù)據(jù)分析，對(duì)6例KMT2D基因突變患兒的臨床及分子生物學(xué)特征進(jìn)行總結(jié)。計(jì)算機(jī)檢索 PubMed、中國(guó)知網(wǎng)、維普、中國(guó)生物醫(yī)學(xué)文獻(xiàn)和萬(wàn)方數(shù)據(jù)庫(kù)，收集KS相關(guān)文獻(xiàn)，檢索時(shí)間從2012年4月至 2017年4月，對(duì)描述新生兒期臨床特征的文獻(xiàn)進(jìn)行提取、歸納和總結(jié)。結(jié)果 6例KS患兒，男4例，女2例。其中3例在嬰兒期均因KS相關(guān)臨床表現(xiàn)，家屬要求行家系WES確診，1例新生兒經(jīng)臨床panel檢測(cè)后確診，2例因家屬要求對(duì)患兒進(jìn)行WES測(cè)序確診。6例KS患兒共檢測(cè)到7個(gè)KMT2D基因的雜合突變，分別位于11、39、51和53號(hào)外顯子，包括1個(gè)終止、4個(gè)錯(cuò)義和2個(gè)移碼突變。其中c.12697C>T(p.Q4233X)、c.16498C>T(p.R5500W)、c.16273G>A(p.E5425K)為人類基因突變數(shù)據(jù)庫(kù)(HGMD)已收錄的致病突變位點(diǎn)。c.12696G>T(p.Q4232H)、c.3495delC (p.Pro1165LeufsTer47)、c.10881delT(p.Leu3627ArgfsTer31)、c.12560G>A(p.G418E)為新發(fā)突變位點(diǎn)。經(jīng)SIFT、Polyphen 2和MutationTaster 軟件預(yù)測(cè)為有害突變。納入18篇KS新生兒期起病文獻(xiàn)加上本文2例(34例)，新生兒期表現(xiàn)為喂養(yǎng)困難(19例)，心臟發(fā)育異常(20例)，特殊容貌(17例)，骨骼發(fā)育異常(15例)，低血糖(10例)和肌張力低下(9例)等。結(jié)論 KS的典型臨床表型在新生兒期還未完全呈現(xiàn)，當(dāng)新生兒有喂養(yǎng)困難、心臟發(fā)育異常、特殊容貌等臨床特征時(shí)需考慮KS，并盡早完善相關(guān)基因檢測(cè)，實(shí)現(xiàn)早診斷、早干預(yù)。

Kabuki綜合征；KMT2D基因； 新生兒臨床特征； 遺傳學(xué)特征

Kabuki綜合征(KS，OMIM 147920)，又稱“歌舞伎臉譜綜合征”，是以生后發(fā)育遲緩、肌張力低下和先天性臟器畸形等為主要臨床表型的多發(fā)畸形綜合征[1,2]。其中，Ⅰ型是由賴氨酸特定的甲基轉(zhuǎn)移酶2D(KMT2D)突變導(dǎo)致，呈常染色體顯性遺傳[3]。目前，已確診的KS患兒44%～76%由KMT2D突變引起[4～7]。Ⅱ型由位于X染色體的賴氨酸去甲基轉(zhuǎn)移酶6A (KDM6A)突變引起(1%～6%)，呈X連鎖顯性遺傳[1,8]。由于KS的一些典型表型隨著年齡的增長(zhǎng)才會(huì)出現(xiàn)，如瞼裂長(zhǎng)、上瞼下翻等往往在童年期才較明顯，故早期臨床診斷困難[9]。目前，超過(guò)92%的確診KS的患兒均因臨床特征出現(xiàn)后再行基因測(cè)序確診[1]，此時(shí)患兒已出現(xiàn)智力發(fā)育落后等表現(xiàn)。高通量測(cè)序技術(shù)可以從基因水平對(duì)遺傳病進(jìn)行早期、精確診斷。本文采用全外顯子組測(cè)序(WES)及臨床panel測(cè)序技術(shù)，結(jié)合復(fù)旦大學(xué)附屬兒科醫(yī)院(我院)分子診斷中心建立的數(shù)據(jù)分析流程[10]，分析6例KMT2D突變KS患兒的臨床表型和分子生物學(xué)特征。

1 病例資料

1.1 臨床資料 6例KS患兒，男4例，女2例，基本情況和臨床特征見(jiàn)表1。

例1～3因“生后生長(zhǎng)發(fā)育遲緩”在我院就診，就診時(shí)2 ～10月齡，有典型的眼部特征和大耳(圖1A)，例1有乳房早發(fā)育(圖1B)和胎指墊(圖1C)等；例4因“生后反應(yīng)差、喂養(yǎng)困難”住我院NICU，就診日齡為21 d，心臟超聲提示：全心增大、心功能不全、繼發(fā)型小房缺和卵圓孔未閉等；例5(3個(gè)月)因外院發(fā)現(xiàn)“先天性心臟病、呼吸困難”和例6(7 d，棄嬰)因“肛門閉鎖”考慮遺傳性疾病，送血標(biāo)本至我院診斷，缺乏臨床信息描述。5例患兒或無(wú)或不清楚家族史。目前例1～4尚在治療中，例5死亡，例6預(yù)后不詳。

1.2 測(cè)序結(jié)果 例1～5在征得父母知情同意后行基因檢測(cè)，其中例1～3行家系WES測(cè)序，例4行新生兒panel檢測(cè)，例5和6行患兒WES測(cè)序，并結(jié)合Sanger 測(cè)序驗(yàn)證。

圖1 KS患兒特征

表1 6例KS患兒基本情況和臨床特征

采患兒和/或父母外周靜脈血2 mL，抽提基因組DNA(Qiagen公司mini blood 全血試劑盒)。參照SureSelct Human All Exon 試劑盒說(shuō)明書進(jìn)行捕獲、建庫(kù)，采用Illumina HiSeq 2000 平臺(tái)對(duì)全基因組編碼區(qū)外顯子進(jìn)行測(cè)序，捕獲目標(biāo)序列50 Mb，總體測(cè)序覆蓋度達(dá)95%。依據(jù)文獻(xiàn)[10]數(shù)據(jù)分析流程，結(jié)合WuXi Next CODE 分析軟件(CSA)進(jìn)行分析。測(cè)序數(shù)據(jù)通過(guò)Burrows-Wheeler Aligner(BWA)與NCBI RefSeq 進(jìn)行匹配比對(duì)，通過(guò)ANNOVAR、VEP軟件以及注釋程序注釋變異數(shù)據(jù)，包括用NCBI RefSeq、SwissPort進(jìn)行基因注釋，HGMD、OMIM、ClinVar進(jìn)行疾病相關(guān)注釋，千人基因組計(jì)劃、EVC6500、ExAC、內(nèi)部數(shù)據(jù)庫(kù)進(jìn)行突變頻率注釋以及SIFT、Polyphen 2、MutationTaster 進(jìn)行突變預(yù)測(cè)。通過(guò)頻率及變異類別的篩選以及與疾病的相關(guān)關(guān)系，篩選出候選突變。

表2顯示，6例KS患兒檢測(cè)到7個(gè)KMT2D基因的雜合突變，分別位于11、39、51和53號(hào)外顯子，突變類型為：1個(gè)終止、4個(gè)錯(cuò)義和2個(gè)移碼突變。其中c.12697C>T(p.Q4233X)、c.16498C>T(p.R5500W)、c.16273G>A(p.E5425K)為人類基因突變數(shù)據(jù)庫(kù)(HGMD)已收錄的致病突變位點(diǎn)。c.12696G>T(p.Q4232H)、c.3495delC(p.Pro1165LeufsTer47)、c.10881delT(p.Leu3627ArgfsTer31)和c.12560G>A(p.G418E)均為新發(fā)突變位點(diǎn)。例4～6未進(jìn)行父母驗(yàn)證，不能明確變異來(lái)源，其余3例均經(jīng)PCR-Sanger測(cè)序驗(yàn)證，為患兒的新發(fā)突變。

表2 6例KS患兒測(cè)序結(jié)果

2 文獻(xiàn)復(fù)習(xí)

檢索 PubMed、中國(guó)期刊全文數(shù)據(jù)庫(kù)、中文科技期刊數(shù)據(jù)庫(kù)、 中國(guó)生物醫(yī)學(xué)文獻(xiàn)數(shù)據(jù)庫(kù)和萬(wàn)方數(shù)據(jù)庫(kù)，檢索時(shí)間均從2012年4月至2017年4月。以 PubMed 數(shù)據(jù)庫(kù)為例，英文檢索式為“(Kabuki [Title/Abstract])”，以CBM 為例，中文檢索式為“Kabuki OR歌舞伎綜合征”。采用主題和自由途徑結(jié)合方式檢索，篩選出新生兒期起病的KS綜合征的文獻(xiàn)，排除綜述類文獻(xiàn)中重復(fù)報(bào)道病例。共納入18篇文獻(xiàn)，均為英文文獻(xiàn)。

表3匯總了包括本文2例在內(nèi)的34例KS患兒在新生兒期的表現(xiàn)，常見(jiàn)的為喂養(yǎng)困難19例，心臟發(fā)育異常20例，特殊容貌17例，骨骼發(fā)育異常15例，低血糖10例，肌張力低下9例，唇腭裂8例，腎臟發(fā)育異常7例，乳房發(fā)育異常4例，生殖器異常5例，呼吸困難4例，小頭畸形2例。

3 討論

KMT2D基因位于染色體12q13.12，全長(zhǎng)19.4 kbp，包含54個(gè)外顯子[29]。目前，HGMD已收錄的KMT2D基因突變類型共558種，其中錯(cuò)義或無(wú)義突變264種、小片段缺失151種、小片段的插入或重復(fù)80種，且多為新發(fā)突變。本文檢測(cè)到的7個(gè)突變中2個(gè)來(lái)自同一患兒(例1)，表現(xiàn)為明顯的精神發(fā)育遲緩，行全基因組拷貝數(shù)變異分析(arrayCGH)未發(fā)現(xiàn)異常。WES檢測(cè)到KMT2D基因外顯子39的2處連續(xù)雜合變異 (c.12697C>C/T, p.Q4233X和c.12696G>G/T， p.Q4232H)。原始測(cè)序數(shù)據(jù)顯示這兩處的變異來(lái)自同一條染色單體，因此這2個(gè)變異也可以表示為2個(gè)連續(xù)的堿基替換(c.12696_12697het_delGCinsAA)。雖該插入缺失位點(diǎn)尚未見(jiàn)報(bào)道，但HGMD已收錄c.12697C>C/T, p.Q4233X位點(diǎn)為KS的致病位點(diǎn)[30]，因此分析該突變?yōu)橛泻ν蛔?。?和3中檢測(cè)到的突變均為新發(fā)移碼突變，導(dǎo)致不能翻譯正常蛋白質(zhì)，患兒表型與KS描述相符，且未檢測(cè)到其父母親攜帶該突變，分析為患兒的新發(fā)突變。例4為新生兒，檢測(cè)到c.16498C>T的突變，該位點(diǎn)是已報(bào)道的KS的致病突變[31]，雖然未出現(xiàn)KS典型的面部特征，但表現(xiàn)為喂養(yǎng)困難、反應(yīng)差、肺部感染、先天性心臟病和隱睪等特征，仍可明確診斷。

KMT2D基因是組蛋白甲基轉(zhuǎn)移酶SET結(jié)構(gòu)域成員之一，參與賴氨酸組蛋白H3K4的三甲基化過(guò)程[32]。在胚胎發(fā)育中，KMT2D是組織細(xì)胞分化的關(guān)鍵調(diào)節(jié)基因[33,34]。研究表明，KMT2D基因?qū)π∈笾炯?xì)胞的生成、肌肉的發(fā)育、巨噬細(xì)胞的活化和淋巴的生成十分必要[35]。文獻(xiàn)認(rèn)為，KS典型的面部特征是KMT2D基因單倍計(jì)量的不足造成的[36]。在對(duì)斑馬魚進(jìn)行KMT2D基因的敲除后，出現(xiàn)了明顯的顱面異常，包括鰓弓完全缺失、軟骨異常、舌骨角畸形和顱蓋骨缺失等[37]。本文確診的6例患兒中，例1～3在嬰兒期逐漸出現(xiàn)多個(gè)系統(tǒng)的畸形，尤其臉部的典型特征(拱形眉、瞼裂長(zhǎng)、上瞼下垂和寬鼻梁)，例1為女性患兒出現(xiàn)胸部發(fā)育和性早熟，符合KS典型的臨床特征[38,2]。KS患兒普遍易患感染，如反復(fù)的中耳炎、上呼吸道感染及肺炎等，其免疫功能異常與中耳炎的遷延不愈相關(guān)[6]。本文確診的6例KS患兒均在不同時(shí)期出現(xiàn)過(guò)反復(fù)的呼吸道感染病史。多項(xiàng)研究表明，KS容易合并其他出生缺陷，除免疫缺陷、甲狀腺炎等合并癥外[39]，還會(huì)有少數(shù)病例合并其他疾病，如毛母細(xì)胞瘤[40]、低血糖、語(yǔ)言功能障礙等[41]。

表3 已報(bào)道的和本文報(bào)告的34 例KS新生兒期的臨床表型

注 例8、10為KDM1A和KDM6A突變，余均為KMT2D突變；NA：未報(bào)告胎兒B超檢查結(jié)果

由于KS涉及人體多個(gè)系統(tǒng)，且病情復(fù)雜，典型的遺傳特征在新生兒期難以明確。本文通過(guò)二代測(cè)序技術(shù)明確診斷6例KS患兒，其中2例為新生兒，補(bǔ)充和豐富了該病的基因突變譜。通過(guò)對(duì)近5年的文獻(xiàn)復(fù)習(xí)，總結(jié)了KS在新生兒期的臨床表型。當(dāng)新生兒存在喂養(yǎng)困難、心臟發(fā)育異常、特殊容貌等臨床特征時(shí)需考慮此病，并盡早完善基因二代測(cè)序輔助診斷，為臨床干預(yù)治療提供依據(jù)，為家庭遺傳咨詢提供線索。

[1] Dentici, ML， Di Pede A, Lepri FR, et al. Kabuki syndrome: clinical and molecular diagnosis in the first year of life. Arch Dis Child.2015,100(2):158-164

[2] Courcet JB, Faivre L, Michot C, et al. Clinical and molecular spectrum of renal malformations in Kabuki syndrome. J Pediatr, 2013, 163(3):742-746

[3] Bogershausen N, Gatinois V, Riehmer V. Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X-Linked Kabuki Syndrome Subtype 2. Hum Mutat, 2016, 37(9): 847-864

[4] Ng SB, Bigham AW, Buckingham KJ, et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet, 2010, 42(9): 790-793

[5] Hannibal MC, Buckingham KJ, Ng SB, et al. Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome. Am J Med Genet, 2011, 155A(7):1511-1516

[6] Micale L, Augello B, Fusco C, et al. Mutation spectrum of MLL2 in a cohort ofKabuki syndrome patients. Orphanet J Rare Dis, 2011, 6:38

[7] Paulussen ADC, Stegmann APA, Blok MJ, et al. MLL2 mutation spectrum in 45 patients with Kabuki syndrome. Hum Mutat, 2011, 32(2): E2018-2025

[8] Paděrová J, Holubová A, Simandlová M, et al. Molecular genetic analysis in 14 Czech Kabuki syndrome patients is confirming the utility of phenotypic scoring. Clin Genet, 2016, 90(3):230-237

[9] Vaux KK, Hudgins L, Bird LM, et al. Neonatal phenotype in Kabuki syndrome. Am J Med Genet, 2005, 132A(3): 244-247

[10] 黎籽秀, 劉博, 徐凌麗, 等. 高通量測(cè)序數(shù)據(jù)分析和臨床診斷流程的解讀. 中國(guó)循證兒科雜志, 2015, 10(1): 19-24

[11] Cappuccio G, Rossi A, Fontana P, et al. Bronchial isomerism in a Kabuki syndrome patient with a novel mutation in MLL2 gene. BMC Med Genet, 2014, 15: 15

[12] Subbarayan A, Hussain K. Hypoglycemia in Kabuki Syndrome. Am J Med Genet A, 2014, 164A(2): 467-471

[13] Siminas S, Baillie CT, Turnock R. Kabuki Syndrome and Anorectal Malformations: Implications for Diagnosis and Treatment. European J Pediatr Surg Rep, 2015, 3(1): 54-58

[14] Giordano P, Lassandro G, Sangerardi M, et al. Autoimmune haematological disorders in two Italian children with Kabuki syndrome. Ital J Pediatr, 2014, 40: 10

[15] Ito N, Ihara K, Tsutsumi Y, et al. Hypothalamic pituitary complications in Kabuki syndrome. Pituitary, 2013, 16(2): 133-138

[16] Gohda Y, Oka S, Matsunaga T, et al. Neonatal case of novel KMT2D mutation in Kabuki syndrome with severe hypoglycemia. Pediatr Int, 2015, 57(4): 726-728

[17] Tunovic S, Barkovich J, Sherr EH, et al. De novo ANKRD11 and KDM1A gene mutations in a male with features of KBG syndrome and Kabuki syndrome. Am J Med Genet A, 2014, 164A(7): 1744-1749

[18] Verhagen JM, Oostdijk W, Terwisscha van Scheltinga CE, et al. An unusual presentation of Kabuki syndrome: clinical overlap with CHARGE syndrome. Eur J Med Genet, 2014, 57(9): 510-512

[19] Lederer D, Shears D, Benoit V, et al. A three generation X-linked family with Kabuki syndrome phenotype and a frameshiftmutation in KDM6A. Am J Med Genet A, 2014, 164A(5): 1289-1292

[20] Kim SJ, Cho SY, Maeng SH, et al. A novel MLL2 gene mutation in a Korean patient with Kabuki syndrome. Korean J Pediatr, 2013, 56(8): 355-358

[21] Tanaka R, Takenouchi T, Uchida K, et al. Congenital corneal staphyloma as a complication of Kabuki syndrome. Am J Med Genet A, 2012, 158A(8): 2000-2002

[22] Long A, Sinkovskaya ES, Edmondson AC, et al. Kabuki syndrome as a cause of non-immune fetal hydrops/ascites. Am J Med Genet A, 2016, 170(12): 3333-3337

[23] McVeigh TP, Banka S, Reardon W. Kabuki syndrome: expanding the phenotype to include microphthalmia and anophthalmia. Clin Dysmorphol, 2015, 24(4): 135-139

[24] Haanp??M, Schlecht H, Batra G, et al. Interrupted/bipartite clavicle as a diagnostic clue in Kabuki syndrome. Am J Med Genet A, 2017, 173(4): 1115-1118

[25] Riess A, Dufke A, Riess O, et al. Mirror-image asymmetry in monozygotic twins with kabuki syndrome. Mol Syndromol, 2012, 3(2): 94-97

[26] Takagi M, Ishii T, Torii C, et al. A novel mutation in SOX3 polyalanine tract: a case of Kabuki syndrome with combined pituitary hormone deficiency harboring double mutations in MLL2 and SOX3. Pituitary, 2014, 17(6): 569-574

[27] Ratbi I, Fejjal N, Micale L, et al. Report of the first clinical case of a Moroccan Kabuki patient with a novel MLL2 mutation. Mol Syndromol, 2013, 4(3): 152-156

[28] Liu S, Hong X, Shen C et al. Kabuki syndrome: a Chinese case series and systematic review of the spectrum of mutations. BMC Med Genet, 2015, 16: 26[29] Micale L, Augello B, Maffeo C, et al. Molecular analysis, pathogenic mechanisms and read through therapy on a large cohort of kabuki syndrome patients. Hum Mutat, 2014, 35(7): 841-850.

[30] Ng SB, Bigham AW, Buckingham KJ, et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet, 2010, 42(9): 790-793

[31] Lin JL, Lee WI, Huang JL, et al. Immunologic assessment and KMT2D mutation detection in Kabuki syndrome. Clin Genet, 2015, 88(3): 255-260

[32] Hu D. Gao X. Morgan MA, et al. The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers. Mol Cell Biol, 2013, 33(32): 4745-4754[33] Smith E, Lin C, Shilatifard A. The super elongation complex (SEC) and MLL in development and disease. Genes Dev, 2011, 25(7): 661-672.

[34] Martin C, Zhang Y. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol, 2005, 6(11): 838-849

[35] Guo C, Chen LH, Huang Y, et al. KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation. Oncotarget, 2013, 4(11): 2144-2153

[36] Ortega-Molina A, Boss IW, Canela A, et al. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development. Nat Med, 2015, 21(11): 1199-1208

[37] Van Laarhoven PM, Neitzel LR, Quintana AM, et al. Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development. Hum Mol Genet, 2015, 24(15): 4443-4453

[38] Schott DA, Blok MJ, Gerver WJ, et al. Growth pattern in Kabuki syndrome with a KMT2D mutation. Am J Med Genet A, 2016, 170(12): 3172-3179

[39] Gürbüz F, ?zalp Yüregir?, Ceylaner S, et al. Coexistence of Kabuki Syndrome and Autoimmune Thyroiditis. J Clin Res Pediatr Endocrinol, 2016,8(1): 105-106

[40] Bernier FE, Schreiber A, Coulombe J, et al. Pilomatricoma Associated with Kabuki Syndrome. Pediatr Dermatol, 2017, 34(1): e26-27

[41] Morgan AT, Mei C, Da Costa A, et al. Speech and language in a genotyped cohort of individuals with Kabuki syndrome. AmJ Med Genet A, 2015, 167(7): 1483-149

(本文編輯：張崇凡，孫晉楓)

Report of 6 Kabuki syndrome cases caused by KMT2D gene mutation and literature review

WUBing-bing1,3,4,SUYa-jie2,4,WANGHui-jun1,ZHANGPing1,LILong2,5,ZHOUWen-hao1,3,5

(1Children'sHospitalofFudanUniversity,ShanghaiKeyLaboratoryofBirthDefects,TheTranslationalMedicineCenterofChildrenDevelopmentandDiseaseofFudanUniversity,Shanghai201102,China; 2DepartmentofNeonatology,People'sHospitalofXinjiangUygurAutonomousRegion,Urumqi830001,China; 3KeyLaboratoryofNeonatalDiseases,MinistryofHealth,Shanghai201102,China; 4.Co-firstauthor；5.Co-correspondingauthor)

Corresponding Author：ZHOU Wen-hao, E-mail: zhouwenhao@fudan.edu.cn; LI Long, E-mail::lilong65@126.com

ObjectiveTo investigate the clinical and genetic features of Kabuki syndrome caused byKMT2Dmutation and summarize the clinical features in neonate. MethodsUsing Whole-Exome Sequencing (WES) and Clinical panel deep sequencing，combined with data analysis pipeline established by molecular diagnostic center of Children's Hospital of Fudan University, the clinical and molecular features of 6 children withKMT2Dmutations were summarized. Databases including PubMed，CNKI，WanFang Database and VIP were searched to collect literature of KS, which describe the clinical features of neonatal period from April 2012 to April 2017. ResultsFour males and two females were diagnosed as KS. Three cases were diagnosed by WES due to KS related manifestations were present and the families came to order trio-WES. One case was diagnosed by clinical neonatal panel screening. Another two cases were diagnosed by WES. Seven heterozygous mutations were detected in six patients with KS，mutations were located in exon 11, exon 39, exon 51 and exon 53 respectively. The types of mutations were one stop gained, four missenses and two frameshifts. Mutation of c.12697C>T(p.Q4233X)、c.16498C>T(p.R5500W)、c.16273G>A(p.E5425K)were reported as pathogenic mutations and had recorded in Human Gene Mutation Database (HGMD). Mutation of c.12696G>T(p.Q4232H), c.3495delC (p.Pro1165LeufsTer47), c.10881delT (p.Leu3627Argfs Ter31)and c.12560G>A(p.G418E)were novel, which predicted as harmful variants by SIFT, polyphen 2 and MutationTaster software. In a total of 18 literatures，together with the 2 cases in this study, there were 34 neonates were included. The most common clinical features were as follows: feeding problem was in 19cases, cardiac dysplasia in 20 cases, special appearance in 17 cases, skeletal dysplasia in 15 cases, hypoglycemia in 10 cases and hypotonia in 9 cases. ConclusionThe typical clinical features of KS are not shown in the neonatal period. This disease should be considered when the newborn has feeding problem, abnormal cardiac morphololy, special appearance and other clinical features. Genetic test can help to diagnose earlier in clinical. Early diagnosis can provide accurate information to clinic, may help patients to acquire appropriate treatment and family genetic counseling.

Kabuki syndrome;KMT2Dgene; Neonatal clinical features; Genetic features

上海市衛(wèi)生和計(jì)劃生育委員會(huì)基金面上項(xiàng)目：201440628

1 復(fù)旦大學(xué)附屬兒科醫(yī)院，上海市出生缺陷防治重點(diǎn)實(shí)驗(yàn)室，復(fù)旦大學(xué)兒童發(fā)育與疾病轉(zhuǎn)化醫(yī)學(xué)研究中心 上海，201102；2 新疆維吾爾自治區(qū)人民醫(yī)院新生兒科 烏魯木齊，830001；3 衛(wèi)生部新生兒疾病重點(diǎn)實(shí)驗(yàn)室 上海，201102；4 共同第一作者；5 共同通訊作者

周文浩，E-mail: zhouwenhao@fudan.edu.cn; 李龍，E-mail: lilong65@126.com

10.3969/j.issn.1673-5501.2017.02.011

2017-03-20

2017-04-20)